Radiopharmaceuticals continue to reshape oncology strategy.
Regeneron’s entry into radiopharma through its partnership with Telix investing $40M upfront across up to four oncology programmes, with milestones reaching $2.1B is a clear signal of where the market is heading.
As major players expand beyond antibodies into targeted radiation therapies, the demand for end-to-end TRP development insight has never been greater.
With the global radioligand therapy market projected to surge over the next decade and therapies moving earlier in treatment pathways, the momentum behind targeted radiopharmaceuticals has never been stronger.
However, this progress is not without its challenges. Limited access to specialised clinical trial sites, supply chain and isotope availability constraints, complex target biology and RLT design decisions, preclinical model limitations, and the well-documented difficulty of progressing assets from Phase 1 to Phase 2 remain persistent hurdles across the field.
That’s why this year’s 5th Targeted Radiopharmaceuticals Summit brings together 66+ industry leading experts across discovery, preclinical, clinical, translation, and CMC (including 3 speakers from Telix) offering the most comprehensive view of the full radiopharmaceutical development lifecycle and direct access to the teams shaping the field.
Built with content shaped by 2025 feedback and market research to focus on the topics the field cares about most, this year’s agenda provides insights which are more actionable than ever.
Explore the full program and expert speaker faculty here: https://ter.li/hjx50stn
What’s new for 2026
- 66+ speakers (including 45 new faces!) featuring leading KOLs and biopharma innovators, including Novartis, RayzeBio, Mariana Oncology, AstraZeneca, Eli Lilly, and many more.
- 4 tracks of content: Discovery, Preclinical, Translational & Clinical, and CMC & Sourcing.
- A Scientific Advisory Board that helps to guide and ensure the calibre of the content meets your expectations.
- 1-2-1 partnering sessions giving you face-to-face opportunities with potential RLT collaborators.
This is your opportunity to connect with the teams behind the progress and equip yourself and your entire team with the insights and strategies needed to address all aspects of TRP development – from discovery to commercialisation.
Register now to save up to $800: https://ter.li/k6a72xs8